It induces the less efficient mode of glycolysis i.e., aerobic glycolysis, and also upregulates GLUT1 and GLUT3 expression resulting in uptake of glucose from the environment thereby increasing the rate of glycolysis in cancer cells (72, 85). The gene discussed is SLC2A3; the disease is cancer.